10.1016/j.jacc.2022.06.023
Journal article
2022-09-06T00:00:00+00:00
80
1011 - 1013
2
GRACE, NSTE-ACS, cathepsin S, reclassification, residual risk, risk stratification, Acute Coronary Syndrome, Biomarkers, Cathepsins, Humans, Risk Assessment